Human IgG Short-Term Sensitizing Anaphylactic Antibody: Differences in Properties from Those of IgG4

[1]  W. Parish.  THE CLINICAL RELEVANCE OF HEAT‐STABLE, SHORT‐TERM SENSITIZING ANAPHYLACTIC IgG ANTIBODIES (IgG S‐TS) AND OF RELATED ACTIVITIES OF IgG4 AND IgG2 , 1981, The British journal of dermatology.

[2]  D. Moneret-vautrin,et al.  Anaphylaxis due to succinylcholine , 1981, Clinical allergy.

[3]  W. D. Brighton.  Frequency of occurrence of IgG (S‐TS) , 1980, Clinical allergy.

[4]  L. Wide,et al.  Clinical correlations between long‐term (IgE) and short‐term (IgG S‐TS) anaphylactic antibodies in atopic and ‘non‐atopic’ subjects with respiratory allergic disease , 1979, Clinical allergy.

[5]  J. Pepys,et al.  Passive transfer in man and the monkey of Type I allergy due to heat labile and heat stable antibody to complex salts of platinum , 1979, Clinical allergy.

[6]  D. Strong,et al.  Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody. , 1978, The Journal of allergy and clinical immunology.

[7]  M. K. Bach.  Immediate hypersensitivity : modern concepts and developments , 1978 .

[8]  W. D. Brighton,et al.  Familial human short‐term sensitizing (IgG S‐TS) antibody , 1977, Clinical allergy.

[9]  H. Vijay,et al.  Inhibition of reagin-mediated PCA reactions in monkeys and histamine release from human leukocytes by human IgG4 subclass. , 1977, International archives of allergy and applied immunology.

[10]  L. Lazarus,et al.  Identification of IgG antibody as a carrier of reaginic activity in asthmatic patients. , 1975, The Journal of allergy and clinical immunology.

[11]  L. Lazarus,et al.  New Type of Allergic Asthma due to IgG “Reaginic” Antibody , 1973, British medical journal.

[12]  D. Stanworth,et al.  Inhibition of reagin‐mediated PCA reactions in baboons by the human IgG4 sub‐class , 1973, Clinical allergy.

[13]  K. Austen,et al.  Asthma: physiology, immunopharmacology, and treatment , 1973 .

[14]  W. Parish.  Short-term anaphylactic IgG antibodies in human sera. , 1970, Lancet.